ESC 365 - Randomised comparison of clopidogrel versus ticagrelor or prasugrel in patients of 70 years or older with non-ST-elevation acute coronary syndrome - POPular AGE

ESC Premium Access

Randomised comparison of clopidogrel versus ticagrelor or prasugrel in patients of 70 years or older with non-ST-elevation acute coronary syndrome - POPular AGE

Session: Late Breaking Science in Acute Coronary Syndromes 1

Topic: Pharmacotherapy

Speaker: Miss M. Gimbel (Nieuwegein, NL)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Miss Marieke Elisabeth Gimbel

St Antonius Hospital, Nieuwegein (Netherlands (The))

1 presentation

0 follower

3 more presentations in this session

A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes: The Australian GRACE Risk score Intervention Study

Speaker: Professor D. Brieger (Concord, AU)

Evolocumab for Early Reduction of LDL-Cholesterol Levels in Patients with Acute Coronary Syndromes

Speaker: Doctor K. Koskinas (Bern, CH)

COMBinAtion Therapy with remote ischemic conditioning and exenatide in Myocardial Infarction. Primary results of The COMBAT-MI trial

Speaker: Doctor I. Otaegui Irurueta (Barcelona, ES)

Access the full session

Late Breaking Science in Acute Coronary Syndromes 1

Speakers: Miss M. Gimbel, Professor D. Brieger, Doctor K. Koskinas, Doctor I. Otaegui Irurueta

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources